The Stem Cell Blog – Page 946

Stem Cell Therapy Among Hot Topics at AAO 2017 – Medscape

2017-11-03 Michael Zand NEWS

Comprehensive Analysis on Allergy Immunotherapy Market & Global Foresight to 2023 – Medgadget (blog)

Medgadget (blog)Comprehensive Analysis on Allergy Immunotherapy Market & Global Foresight to 2023Medgadget (blog)Allergy Immunotherapy market is expected to grow at the CAGR of ~10.85% during the forecast period and is estimated to reach USD 4,… Continue reading

2017-11-03 Michael Zand NEWS

Tuning the Microbiome Improves Melanoma Immunotherapy Response – Genetic Engineering & Biotechnology News (press release)

Genetic Engineering & Biotechnology News (press release)Tuning the Microbiome Improves Melanoma Immunotherapy ResponseGenetic Engineering & Biotechnology News (press release)A probiotic regimen might be a good addition to patients that receive anti-pro… Continue reading

2017-11-03 Michael Zand NEWS

Tuning the Microbiome Improves Melanoma Immunotherapy Response – Genetic Engineering & Biotechnology News (press release)

2017-11-03 Michael Zand NEWS

Analyzing Crispr Theraptc (CRSP) and Editas Medicine (EDIT) – Dispatch Tribunal

Analyzing Crispr Theraptc (CRSP) and Editas Medicine (EDIT)Dispatch TribunalCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf… Continue reading

2017-11-03 Michael Zand NEWS

Syngenta obtains license from Broad Institute for CRISPR technology – Feedstuffs

Syngenta obtains license from Broad Institute for CRISPR technologyFeedstuffs“Gaining access to CRISPR-Cas9 technology will allow us to accelerate the rate of innovation in the development of new plant varieties, and bring novel traits into the hands o… Continue reading

2017-11-03 Michael Zand NEWS

Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarket – Seeking Alpha

Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarketSeeking AlphaSarepta Therapeutics (NASDAQ:SRPT) is up 1% premarket on light volume on the heels of its announcement that the FDA has signed off on its IND for ge… Continue reading

2017-11-03 Michael Zand NEWS

1
…
944
945
946
947
948
…
2,487

Medscape

Stem Cell Therapy Among Hot Topics at AAO 2017
Medscape
Investigators will report the latest findings on the use of human embryonic stem cell–derived retinal pigment epithelial cells, which could restore vision to persons with Stargardt’s macular dystrophy and non-neovascular (dry) macular degeneration. The …

Login

Cart

Tag Archives: The Stem Cell Blog

Scientists are using CRISPR gene-editing tool to make low-fat pigs, study says – Toronto Star

Stem Cell Therapy Among Hot Topics at AAO 2017 – Medscape

Comprehensive Analysis on Allergy Immunotherapy Market & Global Foresight to 2023 – Medgadget (blog)

Tuning the Microbiome Improves Melanoma Immunotherapy Response – Genetic Engineering & Biotechnology News (press release)

Tuning the Microbiome Improves Melanoma Immunotherapy Response – Genetic Engineering & Biotechnology News (press release)

Analyzing Crispr Theraptc (CRSP) and Editas Medicine (EDIT) – Dispatch Tribunal

Syngenta obtains license from Broad Institute for CRISPR technology – Feedstuffs

Sarepta on go with early-stage study of gene therapy GALGT2 for DMD; shares up 1% premarket – Seeking Alpha